Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004992 · ClinicalTrials.gov registry record · Phase 3
Diabetes Prevention Program
A Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
- 3,234
- Enrollment target
NCT00004992 is a Phase 3 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 3,234 participants.
The verdict
NCT00004992, a Phase 3 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,234 participants
- Enrollment target
Study Summary
The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study has recruited volunteers, who are at high risk of developing diabetes, at twenty-five medical centers in the United States. It is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, and other Institute and corporate sponsors. Researchers will evaluate the efficacy of a lifestyle intervention and a pharmacological intervention in preventing or delaying Type 2 diabetes in persons with impaired glucose tolerance (IGT). Each person in the study will be followed for 3 to 6 years.
Interventions
- DRUG Placebo
- DRUG Metformin
- BEHAVIORAL Intensive lifestyle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,234 participants |
| Start Date | 1996-07 |
| Est. Completion | 2001-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004992
The ClinicalTrials.gov registry entry for NCT00004992 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00004992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004992 about?
NCT00004992 is a clinical study titled "Diabetes Prevention Program". The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study has recruited volunteers, who are at high risk of developing diabetes, at twenty-five medical cente...
What is the current status of trial NCT00004992?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,234 participants. The study started on 1996-07. Estimated completion is 2001-04.
What interventions are being tested in trial NCT00004992?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), Intensive lifestyle (BEHAVIORAL).
Who is sponsoring clinical trial NCT00004992?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.